Stock Performance Review on Specialized Health Services Industry -- Acadia Healthcare, DaVita, HealthSouth, and MEDNAX

Thursday, June 22, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, June 22, 2017 /PRNewswire/ --

If you want a Stock Review on ACHC, DVA, HLS or MD then come over to http://dailystocktracker.com/register/

and sign up for your free customized report today. On Wednesday, the NASDAQ Composite ended the day at 6,233.95, up 0.74%; the Dow Jones Industrial Average edged 0.27% lower, to finish at 21,410.03; and the S&P 500 closed at 2,435.61, marginally
slipping 0.06%. Losses were broad based as six out of nine sectors finished the trading session in red. DailyStockTracker.com has initiated research reports on the following Specialized Health Services stocks: Acadia Healthcare Co. Inc. (NASDAQ: ACHC), DaVita Inc. (NYSE: DVA), HealthSouth Corp. (NYSE: HLS), and MEDNAX Inc. (NYSE: MD). Daily Stock Tracker published comprehensive and free research reports on these stocks today at:

http://dailystocktracker.com/register/

Acadia Healthcare 

Franklin, Tennessee headquartered Acadia Healthcare Co. Inc.'s stock finished Wednesday's session 0.07% lower at $45.39 with a total trading volume of 852,562 shares. The Company's shares have advanced 3.87% in the past month, 15.00% in the previous three months, and 37.13% since the start of this year. The stock is trading 3.75% above its 50-day moving average and 8.42% above its 200-day moving average. Additionally, shares of Acadia Healthcare, which develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the US, the UK, and Puerto Rico, have a Relative Strength Index (RSI) of 57.31. ACHC complete research report is just a click away and free at:

http://dailystocktracker.com/registration/?symbol=ACHC

DaVita 

On Wednesday, shares in Denver, Colorado headquartered DaVita Inc. recorded a trading volume of 1.45 million shares, which was above their three months average volume of 1.35 million shares. The stock ended the session 1.21% lower at $64.29. The Company's shares have advanced 0.14% on an YTD basis. The stock is trading 0.96% below its 200-day moving average. Moreover, shares of DaVita, which provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease, have an RSI of 42.55. The complimentary report on DVA can be downloaded at:

http://dailystocktracker.com/registration/?symbol=DVA

HealthSouth 

Birmingham, Alabama headquartered HealthSouth Corp.'s shares closed the day 0.34% lower at $47.37. The stock recorded a trading volume of 1.35 million shares, which was higher than its three months average volume of 933,180 shares. The Company's shares have gained 2.00% in the last month, 14.56% over the previous three months, and 14.86% on an YTD basis. The stock is trading 3.05% and 12.05% above its 50-day and 200-day moving averages, respectively. Additionally, shares of HealthSouth, which provides facility-based and home-based post-acute healthcare services in the US, have an RSI of 61.27.

On June 15th, 2017, research firm KeyBanc Capital Markets initiated a 'Sector Weight' rating on the Company's stock. Sign up for your complimentary research report on HLS at:

http://dailystocktracker.com/registration/?symbol=HLS

MEDNAX 

Shares in Sunrise, Florida headquartered MEDNAX Inc. finished 0.16% higher at $57.82. The stock recorded a trading volume of 860,834 shares. The Company's shares have advanced 6.80% in the last one month. The stock is trading below its 50-day moving average by 0.78%. Furthermore, shares of MEDNAX, which together with its subsidiaries, provides neonatal, anesthesia, maternal-fetal, and other pediatric subspecialties physician services in the US and Puerto Rico, have an RSI of 57.39.

On May 30th, 2017, research firm Mizuho reiterated its 'Neutral' rating on the Company's stock with a decrease of the target price from $64 a share to $58 a share. Get free access to your research report on MD at:

http://dailystocktracker.com/registration/?symbol=MD

Daily Stock Tracker: 

Daily Stock Tracker (DST) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. DST has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

DST has not been compensated; directly or indirectly; for producing or publishing this document. 

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email [email protected]. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by DST. DST is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  

NO WARRANTY 

DST, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. DST, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, DST, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 

NOT AN OFFERING 

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither DST nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

http://dailystocktracker.com/disclaimer/

CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: [email protected] Phone number: (207)331-3313 Office Address: 377 Rivonia Boulevard, Rivonia, South Africa

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Chelmsford Park SA



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store